Product Program year 2025 Source: CMS Open Payments

Altreno

Drug Dermatology

NDC 0187-0005-45

Open in the dashboard

General payments

$1,056,099

8,197 payments

Research payments

$211,881

12 payments

Through program year 2025, $1,056,099 in general payments and $211,881 in research payments were reported against Altreno (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

11 rows
Year Kind Amount Payments
2025 General $10,243 50
2024 General $8,234 70
2023 General $49,495 169
2022 General $126,368 159
2022 Research $101,916 4
2021 General $59,098 1,459
2021 Research $28,615 2
2020 General $65,485 1,383
2020 Research $40,700 3
2019 General $737,176 4,907
2019 Research $40,650 3

Breakdown

Who paid General payments · program years 2019–2025
  1. Ortho Dermatologics, a division of Bausch Health US, LLC $1,055,769 8,192 payments
  2. Solta Medical, a division of Bausch Health US, LLC $281 3 payments
  3. Bausch Health US, LLC $30 1 payment
  4. Bausch & Lomb, a division of Bausch Health US, LLC $20 1 payment
Top recipients General payments · program year 2025
  1. Hilary Baldwin Dermatology · Brooklyn, NY $2,850 28% · 1 payment
  2. Leon Kircik Dermatology · Lousiville, KY $2,800 27% · 1 payment
  3. Christie Matter Dermatology · Prosper, TX $252 2% · 2 payments
  4. Kyle Owens Dermatology · Prosper, TX $252 2% · 2 payments
  5. Drew Kuraitis Dermatology · Buffalo, NY $206 2% · 2 payments

The top 5 of 46 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $8,292 86% · 23 practitioners
  2. Physician Assistant $353 4% · 5 practitioners
  3. Nurse Practitioner $242 3% · 3 practitioners
  4. Internal Medicine $132 1% · 2 practitioners
  5. Clinical & Laboratory Dermatological Immunology Dermatology $116 1% · 1 practitioner

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $2,940 29% · 2 recipients
  2. Kentucky $2,800 27% · 1 recipient
  3. Louisiana $1,031 10% · 7 recipients
  4. Texas $982 10% · 8 recipients
  5. West Virginia $791 8% · 7 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

36

Prescriptions dispensed, refills included

Drug cost

$2,680

Paid at the pharmacy, in all

Prescribers

3

With 11 or more claims of it

Medicare Part D drugs matched to ALTRENO, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Altreno Tretinoin Same name 3 36 $2,680

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

3 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Robert Weinberg Dermatology NY 13 $904 None on record
Joel Max Dermatology MD 12 $890 None on record
Howard Hines Dermatology MD 11 $886 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

8,197 general · 12 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record